One-step assembly of polymeric demethylcantharate prodrug/Akt1 shRNA complexes for enhanced cancer therapy.

[1]  Hui-zhen Jia,et al.  Fabrication of dual responsive co-delivery system based on three-armed peptides for tumor therapy. , 2016, Biomaterials.

[2]  Yi Yan Yang,et al.  Co-delivery of drugs and plasmid DNA for cancer therapy. , 2016, Advanced drug delivery reviews.

[3]  K. Nakashiro,et al.  Identification of Akt1 as a potent therapeutic target for oral squamous cell carcinoma. , 2015, International journal of oncology.

[4]  U. Schubert,et al.  Multifunctional poly(methacrylate) polyplex libraries: A platform for gene delivery inspired by nature. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[5]  Li-xin Zhang,et al.  Short hairpin RNA targeting AKT1 and PI3K/p85 suppresses the proliferation and self-renewal of lung cancer stem cells. , 2015, Molecular medicine reports.

[6]  Xin-ping Li,et al.  Norcantharidin enhances TIMP‑2 anti‑vasculogenic mimicry activity for human gallbladder cancers through downregulating MMP‑2 and MT1‑MMP. , 2015, International journal of oncology.

[7]  Lei Xing,et al.  A novel potential biocompatible hyperbranched polyspermine for efficient lung cancer gene therapy. , 2015, International journal of pharmaceutics.

[8]  Megan E Godsey,et al.  Materials innovation for co-delivery of diverse therapeutic cargos. , 2013, RSC advances.

[9]  Manman Guo,et al.  Determination and pharmacokinetic study of the diacid metabolite of norcantharidin in beagle plasma by use of liquid chromatography–tandem mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.

[10]  Byungkuk Kim,et al.  Acid-cleavable ketal containing poly(β-amino ester) for enhanced siRNA delivery. , 2013, International journal of pharmaceutics.

[11]  Jun Li,et al.  FGFR-targeted gene delivery mediated by supramolecular assembly between β-cyclodextrin-crosslinked PEI and redox-sensitive PEG. , 2013, Biomaterials.

[12]  Bing Xu,et al.  Disruption of the dynamics of microtubules and selective inhibition of glioblastoma cells by nanofibers of small hydrophobic molecules. , 2013, Angewandte Chemie.

[13]  Toshinori Sato,et al.  The effects of coating pDNA/chitosan complexes with chondroitin sulfate on physicochemical characteristics and cell transfection. , 2012, Biomaterials.

[14]  D. Oupický,et al.  Dual-function CXCR4 antagonist polyplexes to deliver gene therapy and inhibit cancer cell invasion. , 2012, Angewandte Chemie.

[15]  Fei Wu,et al.  Polyspermine imidazole-4,5-imine, a chemically dynamic and biologically responsive carrier system for intracellular delivery of siRNA. , 2012, Angewandte Chemie.

[16]  Jianbin Tang,et al.  Targeted acid-labile conjugates of norcantharidin for cancer chemotherapy , 2012 .

[17]  A. Attia,et al.  Advanced Materials for Co‐Delivery of Drugs and Genes in Cancer Therapy , 2012, Advanced healthcare materials.

[18]  Shun-Fa Yang,et al.  Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity , 2012, PloS one.

[19]  Xian‐Zheng Zhang,et al.  A strategy to improve serum-tolerant transfection activity of polycation vectors by surface hydroxylation. , 2011, Biomaterials.

[20]  J. Gorman,et al.  Influence of injectable hyaluronic acid hydrogel degradation behavior on infarction-induced ventricular remodeling. , 2011, Biomacromolecules.

[21]  Jun Li,et al.  Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery. , 2011, Biomaterials.

[22]  Kam W Leong,et al.  Simultaneous delivery of siRNA and paclitaxel via a "two-in-one" micelleplex promotes synergistic tumor suppression. , 2011, ACS nano.

[23]  Cheol-Heui Yun,et al.  Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. , 2009, International journal of pharmaceutics.

[24]  Jianjun Cheng,et al.  Ring-opening polymerization-mediated controlled formulation of polylactide-drug nanoparticles. , 2009, Journal of the American Chemical Society.

[25]  J. Nah,et al.  Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[26]  J. Nah,et al.  Chitosan-graft-polyethylenimine as a gene carrier. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Chen Dawei,et al.  A less irritant norcantharidin lipid microspheres: formulation and drug distribution. , 2006, International journal of pharmaceutics.

[28]  Timothy E. Long,et al.  Michael addition reactions in macromolecular design for emerging technologies , 2006 .

[29]  J. Nah,et al.  Degradable polyethylenimine-alt-poly(ethylene glycol) copolymers as novel gene carriers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[30]  D. W. Pack,et al.  A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. , 2003, Bioconjugate chemistry.

[31]  M. Westphal,et al.  Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  P. Krammer,et al.  Tumor Immunology , 2018, Medical Immunology.

[33]  Robert Langer,et al.  Degradable Poly(β-amino esters): Synthesis, Characterization, and Self-Assembly with Plasmid DNA , 2000 .

[34]  Wei Wang,et al.  The biocompatibility of fatty acid modified dextran-agmatine bioconjugate gene delivery vector. , 2012, Biomaterials.